Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P01DK046763, U01DK062413
National Cancer Institute
Grant: U54-CA260591
National Center for Advancing Translational Sciences
Grant: UL1TR001881
NCI NIH HHS
Grant: U54 CA260591
NIDDK NIH HHS
Grant: P01 DK046763
NIDDK NIH HHS
Grant: U01 DK062413
National Institutes of Health
Grant: 2U01DK062413-16
Genetic and genomic approaches to better understand the clinical heterogeneity in inflammatory bowel diseases
National Institutes of Health
Grant: 4U54CA260591-02
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
National Institutes of Health
Grant: 3UL1TR001881-01S2
UCLA Clinical Translational Science Institute
National Institutes of Health
Grant: 5P01DK046763-22
IBD: Genetic and Immunopathologic Mechanisms
FWCI
1.06
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals